Nadav did both his BSc and MSc at the Hebrew University of Jerusalem. The latter was done at the department of genetics under the guidance of Prof. Ruth Sperling on the structure and composition of the native human spliceosome. Nadav then joined Natan Karin’s lab in mid 2020 as a PhD student, with the aim to study the in-vivo role of T cell CXCR3 ligands CXCL9 and CXCL10 in cancer using a murine model.